Novartis may jettison some of its small businesses

|About: Novartis AG (NVS)|By:, SA News Editor

CEO Joe Jimenez' review of the viability of Novartis' (NVS) small divisions will probably mean that at least one will eventually be sold.

Three units: animal health, vaccines and OTC medicines won't globally scale so it the best solution for shareholders may be to get rid of them.

He cites the unattractive reimbursement environment as the main challenge for the businesses.